World Bulletin / News Desk
Taking aspirin daily may help protect against cancer but the effect seems weaker than previously thought, according to a U.S. study that included a decade's worth of data from more than 100,000 people.
"News about the cancer potential of aspirin use has been really encouraging lately," said Michael Thunof the American Cancer Society, who worked on the study that appeared in the Journal of the National Cancer Institute.
"Things are moving forward, but it is still a work in progress," he said.
Medical guidelines in the United states already urge people to take low doses of aspirin to prevent heart disease if the predicted benefits outweigh the risk of side effects, or if they have already suffered a heart attack.
However, whether those recommendations should be broadened to include cancer prevention remains up in the air.
Earlier this year, an analysis of previous clinical trials showed that people on aspirin were less likely to die of cancer than those not on the medication, with a 37 percent drop in cancer deaths observed from five years onwards.
The new report is based on data from more than 100,000 men and women, most over 60 and all of them non-smokers.
People who said they took daily aspirin, whether "baby" or adult strength, had a 16 percent lower risk of dying from cancer than non-users overall, Thun and his colleagues found.
For men, the difference came out to 103 fewer cancer deaths a year per 100,000 people. For women, the number was 42.
The effect was strongest for gastrointestinal cancer, such as colon cancer and stomach cancer.
Because the study wasn't a clinical trial, it's hard to know if the findings can be chalked up to aspirin or if something else is at play. But Thun said they would favor broadening the aspirin guidelines to include cancer prevention based on an individual risk-benefit assessment.
Other researchers are more sceptical. Kausik Ray of St. George's University of London, who has studied aspirin, said the new study did not look at overall death rates or side effects such as serious stomach bleeds.
Earlier this year, Ray's team published an analysis of previous aspirin trials showing the medication did not prevent deaths from heart disease or cancer, and was likely to cause more harm than good.
One of the problems with the new study, as well as with previous aspirin trials, is something called detection bias, he said. For instance, if somebody develops stomach bleeding from aspirin, they are likely to have their bowels checked by a doctor. This may result in finding and removing tumors or pre-cancerous polyps, which could prolong the patient's life.
So far, most aspirin trials have been designed to test its effect on heart disease. Ray called for trials that specifically check people for new cancers at given intervals to weed out the selection bias marring previous research.
The White House has said a decision will be announced before the G7 summit in Italy on May 26 and 27.
House Freedom Caucus says will back President Donald Trump's healthcare plans
The London-based Environmental Investigation Agency (EIA) estimated that in 2013, at least 93 percent of logging in Mozambique was illegal -- and that most of the illicit timber ended up sold in China.
Erik Solheim told AFP in an interview on Monday that even if the United States withdraws, China and the European Union will step in and take the lead to implement the global agreement on reducing greenhouse gas emissions.
Polyethylene represents 40 percent of Europe's demand for plastic products, mostly in the form of packaging and shopping bags.
The High Court had demanded ministers come up with a plan to tackle illegal levels of nitrogen dioxide pollution, largely caused by diesel emissions, by 3:00 pm (1400 GMT) on Monday.
PEG-2S promises to tackle superbugs that threaten world health
The change affects grazing conditions for the 146,000 or so semi-domesticated reindeer in Norway who feed on lichen and moss under the snow.
The discovery of the giant shipworm, a species never before studied, marked the first time scientists had live specimens in hand, according to an article published this week in American journal Proceedings of the National Academy of Sciences.
As many as one in 45 children are diagnosed with autism spectrum disorder in the United States, according to a recent study by the US Centers for Disease Control and Prevention.
A full 1.6 billion people remain affected by NTDs -- more than 500 million of them children -- but that number is down from more than two billion in 2010, WHO said.
For the first time ever in modern history, a team of scientists Monday documented as what they're describing as large-scale river reorganization as a result of human-caused climate change.
In the next few hours he will receive a healthy kidney thanks to a pioneering system that has made Spain the world leader in organ transplants for the past 25 years.
Japan's corals, the northernmost in the world, could offer important data to bolster knowledge about marine life, as Australia's Great Barrier Reef faces a threat to its survival.
China is the world's largest consumer and producer of tobacco, and the industry provides the government with colossal sums.
During his time leading IAS, Mark Wainberg organised the 13th International AIDS conference in Durban, South Africa, and he also co-chaired the same conference in Toronto in 2006.